Palisade Bio Inc (PALI)
6.38
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
6.67
+0.29
(+4.55%)
After-Hours: 20:00
Palisade Bio Cash from Operations (TTM): -11.13M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.13M |
September 30, 2023 | -11.69M |
June 30, 2023 | -12.07M |
March 31, 2023 | -13.12M |
December 31, 2022 | -13.36M |
Date | Value |
---|---|
September 30, 2022 | -13.11M |
June 30, 2022 | -12.82M |
March 31, 2022 | -17.29M |
December 31, 2021 | -14.77M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.29M
Minimum
Mar 2022
-11.13M
Maximum
Dec 2023
-13.26M
Average
-13.11M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
TG Therapeutics Inc | 20.28M |
Protagenic Therapeutics Inc | -3.704M |
Bio-Path Holdings Inc | -11.54M |
Jaguar Health Inc | -33.24M |
Finch Therapeutics Group Inc | -22.49M |